Clinical Trial Update: Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of Inclisiran on atherosclerotic plaque in patients with acute myocardial infarction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Myocardial Infarction

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Plaque, Atherosclerotic | Phase 4 | Status: RECRUITING